Threshold models in radiation carcinogenesis

Health Physics

Volumn 75, Issue 3, 1998, Pages 241-250

  Hoel, David G ^b   Li, Ping ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b NONE

Author keywords

Atomic bomb survivors; Cancer; Health effects; Risk analysis

Indexed keywords

ARTICLE; ATOMIC BOMB; CANCER INCIDENCE; CANCER MORTALITY; FEMALE; HUMAN; LEUKEMIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIATION DOSE; RADIATION EXPOSURE; RISK ASSESSMENT; SOLID TUMOR; STATISTICAL MODEL;

EID: 0031904794     PISSN: 00179078     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004032-199809000-00002     Document Type: Article

References (14)

1. Cardis, E.; Gilbert, E. S.; Carpenter, L.; Howe, G.; Kato, I.; Armstrong, B. K.; Beral, V.; Cowper, G.; Douglas, A.; Fix, J.; Fry, S. A.; Kaldor, J.; Lavé, C.; Salmon, L.; Smith, P. G.; Voelz, G. L.; Wiggs, L. D. Effects of low doses and low dose rates of external ionizing radiation: cancer mortality among nuclear industry workers in three countries. Radiat. Res. 142:117-132; 1995.
2. Edwards, A. A.; Moiseenko, V. V.; Nikjoo, H. On the mechanism of the formation of chromosomal aberrations by ionising radiation. Radiat. Environ. Biophys. 35:25-30; 1996.
3. Frome, E. L.; Cragle, D. L.; Watkins, J. P.; Shy, C. M.; Tankersley, W. G.; West, C. M. A mortality study of employees of the nuclear industry in Oak Ridge, Tennessee. Radiat. Res. 148:64-80; 1997.
4. Goldman, M. Perspective. Science 271:1821; 1996.
5. Hei, T. K.; Wu, L. J.; Liu, S. X.; Vannais, D.; Waldren, C. A.; Randers-Pehrson, G. Mutagenic effects of a single and an exact number of a particles in mammalian cells. Proc. Natl. Acad. Sci. 94:3765-3770; 1997.
6. Hoel, D. G.; Kaplan, N. L.; Anderson, M. W. Implications of nonlinear kinetics on risk estimation in carcinogensis. Science 219:1032-1037; 1983.
7. Hoel, D. G.; Portier, C. J. Nonlinearity of dose-response functions for carcinogenicity. Enviromental Health Perspectives Supplements 102:109-113; 1994.
8. Howe, G. R. Lung cancer mortality between 1950 and 1987 after exposure to fractionated moderate-dose-rate ionizing radiation in the Canadian fluoroscopy cohort study and a comparison with lung cancer mortality in the Atomic Bomb survivors study. Radiat. Res. 142:295-304; 1995.
9. Kathren, R. L. Pathway to a paradigm: the linear nonthreshold dose-response model in historical context: The American Academy of Health Physics. 1995 Radiology Centennial Hartman Oration. Health Phy. 70:621-635; 1996.
10. Kato, H.; Johnson, K. G.; Yano, K. Mail survey of cardiovascular disease study, Hiroshima and Nagasaki. Hiroshima: Atomic Bomb Casualty Commission; TR 19-66. 1966.
11. Kellerer, A. M.; Barclay, D. Age dependencies in the modeling of radiation carcinogenesis. Radiat. Prot. Dosim. 41:273-281; 1992.
12. Kellerer, A. M.; Nekolla, E. Neutron versus γ-ray risk estimates. Radiat. Environ. Biophys. 36:73-83; 1997.
13. Little, M. P.; Muirhead, C. Evidence for curvilinearity in the cancer incidendence dose-response in the Japanese atomic bomb survivors. International J. Radiat. Biol. 70:83-94; 1996.
14. Mabuchi, K.; Soda, M.; Ron, E.; Tokunaga, M.; Ochikubo, S.; Sugimoto, S.; Ikeda, T.; Terasaki, M.; Preston, D. L.; Thompson, D. E. Cancer incidence in atomic bomb survivors. Part I: Use of the tumor registries in Hiroshima and Nagasaki for incidence studies. Radiat. Res. 137:s1-s16; 1994.